NCT03690167

Brief Summary

The objective of this case-control intervention study is to explore the effectiveness of Concentrated Growth Factor (CGF) and Advanced Platelet Rich Fibrin (A-PRF) on Pain, Edema and Trismus After Impacted Lower Third Molar Surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 12, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 26, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 1, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2019

Completed
Last Updated

August 28, 2019

Status Verified

August 1, 2019

Enrollment Period

8 months

First QC Date

September 26, 2018

Last Update Submit

August 26, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Edema-amount change of swelling

    In order to evaluate the amount change of swelling after the operation, horizontal and vertical measurements will be made from 5 reference points including tragus, lip corner, soft tissue pogonion, lateral cantus of the eye and gonion. The first measurement between the tragus-lip corner, the second measurement will be obtained by measuring the horizontal distance between the tragus-soft tissue pogonion. The third measurement will be determined by the measurement of the vertical distance between the outer corner of the eye and the gonion. to determine the change in the swelling measurements performed before surgery and at 2nd-7th days after surgery.

    Baseline, 2nd and 7th days

Secondary Outcomes (3)

  • Trismus- degree of change (limitation) in maximum mouth opening

    Baseline, 2nd and 7th days

  • Post operative Pain: visual analog (VAS) scale

    6th and 24th hours, 2nd and 7th days

  • Post-operative symptom severity (PoSSe) scale

    Post operative 7th day

Study Arms (3)

Concentrated Growth Factor (CGF)

ACTIVE COMPARATOR

Participants with impacted lower third molar

Other: Concentrated Growth Factor (CGF)

Advanced Platelet Rich Fibrin (A-PRF)

ACTIVE COMPARATOR

Participants with impacted lower third molar

Other: Advanced Platelet Rich Fibrin (A-PRF)

Control

SHAM COMPARATOR

Participants with impacted lower third molar

Other: Control

Interventions

CGF application (9 ml venous blood will harvested from the participants in the CGF group and centrifuged according to the protocol for CGF)

Concentrated Growth Factor (CGF)

A-PRF application (9 ml venous blood will harvested from the participants in the CGF group and centrifuged according to the protocol for A-PRF)

Advanced Platelet Rich Fibrin (A-PRF)
ControlOTHER

Nothing applied after extraction

Control

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients presenting asymptomatic impacted lower third molar tooth in the vertical or mesioanguler position according to the Winter classification, Class I and II ramus relation and class B and C depth according to Pell-Gregory classification
  • Patients between the ages of 18-30,
  • Non-smokers,
  • Patients with ASA I status

You may not qualify if:

  • Who does not want to be volunteer for the study,
  • Do not comply with post-operative recommendations,
  • Operation lasting more than 30 minutes,
  • During pregnancy or lactation,
  • Have a chronic systemic disorder that may affect healing.
  • Unable to cooperate,
  • Post-operative infection,
  • Patients with pericoronitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ordu University

Ordu, 52200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

TrismusEdemaPainPostoperative Complications

Condition Hierarchy (Ancestors)

SpasmNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Damla Torul, PhD

    Ordu University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Asistant, Oral and Maxillofacial Surgery

Study Record Dates

First Submitted

September 26, 2018

First Posted

October 1, 2018

Study Start

July 12, 2018

Primary Completion

March 1, 2019

Study Completion

March 20, 2019

Last Updated

August 28, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

IPD can share with other researchers on demand

Locations